HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Quetiapine IR (Immediate Release)

TERMINATED · PHASE3 · Schizophrenia, Schizoaffective Disorders, Psychotic Disorders

Study terminated due to poor recruitment

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.